Wang, Qunbin 汪群斌
Main board
| Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | * | FOSUN INTERNATIONAL LIMITED | ED, Co-FdrExecutive Director, Co-Founder | 2005-08 | 2009-01-16 | -74.08% | -59.20% | -43.38% |
| Pres, Co-FdrPresident, Co-Founder | 2009-01-16 | 2017-03-28 | 430.15% | 22.58% | 10.40% | |||
| CEO, Co-FdrChief Executive Officer, Co-Founder | 2017-03-28 | 2020-02-21 | -0.92% | -0.32% | -7.36% | |||
| Co-Ch, Co-FdrCo-Chairman, Co-Founder | 2020-02-21 | -53.46% | -16.74% | -10.19% | ||||
| 2 | Henan Lingrui Pharmaceutical Company Limited | DirDirector | ||||||
| 3 | MIRACLE NOVA (UK) LIMITED | DirDirector | 2014-12-29 | 2018-06-08 | ||||
| 4 | Shanghai Bailian Group Co., Ltd. | DirDirector | U | |||||
| 5 | * | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | ED, GMExecutive Director, General Manager | 1995-05-31 | 2007 | |||
| ChChairman | 2007-10 | 2010-06 | ||||||
| NEDNon-Executive Director | 2010-06 | 2019-06-25 | 130.54% | 13.38% | 5.29% | |||
| 6 | * | SINOPHARM GROUP CO. LTD. | NEDNon-Executive Director | 2003-01-08 | 2013-11-08 | 13.55% | 3.13% | -1.07% |
| NEDNon-Executive Director | 2013-11-08 | 2019-03-22 | 77.44% | 11.28% | 2.87% | |||
| Average | -3.70% | -6.21% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy